This week we bring you stories about survivors of childhood cancer, for whom researchers say genetics and treatment are key contributors to second cancer risk. We also examine a new liquid biopsy designed to detect residual cancer.
Here’s what’s new this week:
For Survivors of Childhood Cancer, Genetics and Treatment are Key Contributors to Second Cancer Risk
For cancer survivors, recurrence is a real and ever-present concern. But while the threat of cancer coming back following treatment looms large for many, survivors are also at increased risk…
Building on the Success of a New Liquid Biopsy, Researchers Develop Test to Detect Residual Cancer
Last week we brought you a story on a liquid biopsy test showing “superior sensitivity” in detecting HPV-associated head and neck cancers. Researchers at Mass Eye and Ear developed the test –…
